• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

Balion C, Don-Wauchope A, Hill S, et al. Use of Natriuretic Peptide Measurement in the Management of Heart Failure [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Nov. (Comparative Effectiveness Reviews, No. 126.)

Abbreviations

°C

Degrees Celsius

ACC

American College of Cardiology

ACC/AHA

American College of Cardiology/American Heart Association

ACE

Angiotensin Converting Enzyme

ACEI/ARB

angiotensin receptor blocker

aCHF

Acute congestive heart failure

ACID

Automatic Implantable Cardiac Defibrillator

ACS

Acute Coronary Syndrome

ADHF

Acute decompensated heart failure

ADM

admission mean

AF

atrial fibrillation

AHA

American Heart Association

AHF

acute heart failure

AHRQ

Agency for Healthcare Research Quality

AMED

Allied and Complementary Medicine

AMI

Acute myocardial infarction

ANP

A-Type Natriuretic Peptide

AR

Aortic Regurgitation

ARB

Angiotensin receptor blockers

AS

Aortic Stenosis

AUC

Area Under the Curve

AVLD

Asymptomatic Left Ventricular Dysfunction

BACH

Biomarkers in Acute Heart Failure

BASEL

B-Type Natriuretic Peptide for Acute Shortness of Breath Evaluation

BMI

body mass index

BMod

Behavior modification

BNP

B-Type Natriuretic Peptide

BP

Blood pressure

BUN

blood urea nitrogen

CA125

carbohydrate antigen 125

CABG

Coronary Artery Bypass Graft

CAD

coronary artery disease

CCS

Canadian Cardiovascular Society

CES-D

Center for Epidemiologic Studies Depression

cGMP

Cyclic guanosine mononucleotide phosphate

CHD

Chronic heart disease

CHF

congestive heart failure

CI

Confidence Interval

CKD

chronic kidney disease

COPD

chronic obstructive pulmonary disease

CP

cutpoint

CPE

Cardiogenic pulmonary edema

CRF

Chronic renal failure

CRP

C-reactive protein

CRT

Cardiac Resynchronization Therapy

CT

Computerized Tomography

cTnT

cardiac troponin T

CT-proET-1

C-terminal pro-endothelin-1 precursor fragment

CV

Cardiovascular

CVD

Cardiovascular Disease

CXR

Chest radiograph

d

days

D/C

discharge mean

DD

diastolic dysfunction

DIAST-CHF

Diastolic congestive heart failure

DM

diabetes mellitus

DOR

Diagnostic Odds Ratio

Dx

diagnosis

E/A

Early to late (atrial) echocardiographic phases of ventricular filling

ECG

Electrocardiogram

ECHO

Echocardiogram/echocardiography

ECHOES

Echocardiographic Heart of England Screening

ECP

Enhanced Counterpulsation

ED

emergency department

EDTA

Ethylenediaminetetraacetic acid

EF

Ejection Fraction

eGFR

Estimated glomerular filtration rate

ELISA

Enzyme Linked ImmunoSorbent Assay

EPIDASA

Epidemiological study of acute dyspnea in elderly patients

ER

Emergency room

ESC

European Society of Cardiology

F/U

followup

FDA

Food and Drug Administration

FN

False Negative

FPR

False-Positive Rates

g/dl

grams per deciliter

G-CSF

granulocyte colony-stimulating factor

G-CSF

granulocyte colony-stimulating factor

GDF-15

Growth differentiation factor 15

glow

Lower gray zone

GP

General practitioner

gup

Upper gray zone

Hb

Hemoglobin

HbA1c

Hemoglobin A1c

HD

heart disease

HEARD-IT

Heart Failure and Audicor technology for Rapid Diagnosis and Initial Treatment

HF

heart failure

HFnEFESC

Heart failure with normal ejection fraction recommended by European Society of Cardiology

HFrEF Grp

Heart failure with reduced ejection fraction group

HGF

hepatocyte growth factor

HID

Heart ischemic disease

HO

History of

HO HF

history of heart failure

HO of MI

history of myocardial infraction

HR

Hazard ratio

HR

heart rate

hsCRP

high-sensitivity c-reactive protein LVEF

HT

hypertension

IABP

Intra-Aortic Balloon Pump

ICON

International Collaboration of NT‐proBNP

ICU

intensive care unit

IDD

Isolated diastolic dysfunction

IDI

integrated risk improvement

IHD

Idiopathic Heart Disease

IL-6

interleukin-6

IMPROVE-CHF

Improved Management of Patients with Congestive Heart Failure

IQR

Interquartile range

JVP

Jugular Venous Pressure

KCCQ

Kansas City Cardiomyopathy Questionnaire

KD

Kidney disease

kg/m2

kilograms per meter squared

LAD

Left Anterior Descending

LR

Likelihood Ratio

LR-

negative likelihood ratio

LR+

positive likelihood ratio

LV

Left ventricle

LVD

Left Ventricular Dysfunction

LVDD

Left ventricular diastolic dysfunction

LVEDD

Left Ventricular End Diastolic Diameter

LVEF

left ventricular ejection fraction

LVESD

Left Ventricular End Systolic Dimension

LVSD

Left ventricular systolic dysfunction

LVSF

left ventricular systolic function

m

months

M/F

Male or female

MANPRO

Mannheim NT-proBNP Study

MCP-1

monocyte chemoattractant protein 1

M-CSF

macrophage colony-stimulating factor

MEIA

Microparticle enzyme immunoassay

mg/dL

Milligram per deciliter

MI

Myocardial Infarction

MIBG 123

I-metaiodobenzylguanidine

Min

Minutes

ml/min

millimeter per minute

mmol/L

milli mol per Liter

mol/L

mol per Liter

MPO

myeloperoxidase

MRI

Magnetic Resonance Imaging

MRNA

Myocardial Radionuclide Angiogram

MR-proADM

midregional proad- renomedullin

MRproANP

Midregional Pro-A-Type Natriuretic Peptide

MS

Mitral Stenosis

MSHD

Major structural heart disease

MSHD-AF

Major structural heart disease atrial fibrillation

MSHD-SR

Major structural heart disease sinus rhythm

n

number

NA

not applicable

ng/L

Nanogram per liter

NHANES

National Health and Nutrition Examination Survey

NPV

Negative Predictive Value

NR

Not reported

NS

Not stated

NSTEMI

Non ST-Elevation Myocardial Infarction

NT

N-Terminal

NTproBNP

N-terminal pro-B-type natriuretic peptide

NYHA

New York Heart Association

OR

odds ratio

PANAMA

Patients with suspected heart failure in primary care

PCI

Percutaneous coronary intervention

PCWP

Pulmocapillary wedge pressure

PEDF

pigment epithelium-derived factor

pg/ml

Picograms per milliliter

pmol/L

Picomol per liter

PPV

Positive predictive value

PRIDE

Pro-BNP investigation of dyspnea in the emergency department

PRIMA

PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality

PROTECT

NT-proBNP Testing to Guide Heart Failure Therapy in the Outpatient Setting

PTCA

Percutaneous Transluminal Coronary Angioplasty

pts

patients

PVB

Premature Ventricular Beat

QoL

quality of life

QRS

Quick release system

QUADS

Quality Assessment of Diagnostic Accuracy Studies

RCT

Randomized controlled trial

RDW

Red blood cell distribution width

RNA

Radionuclide Angiogram

ROC

rate of change

ROC

Receiver operating characteristic

RR

Relative Risk

RV

right ventricular

RVD

Right ventricular dysplasia

S3 gallop

heart sounds, rhythm

SBP

Systolic blood pressure

SD

Standard deviation

Serum TC

serum total cholesterol

sFAS

soluble apoptosis-stimulating fragment

SIGNAL-HF

Swedish Intervention study –Guidelines and NT-proBNP Analysis in Heart Failure

SR

Sinus rhythm

SROC

Summary Receiver Operator Characteristic

SRS

Systematic Review Software

ST2

a gene product

STARBRITE

Strategies for Tailoring Advanced Heart Failure Regimens in the outpatient setting

STEMI

ST-Elevation Myocardial Infarction

sTweak

soluble tumour necrosis factor-like weak inducer of apoptosis

TC

Tetracycline

TDI

tissue Doppler imaging

TEP

Technical Expert Panel

TGF beta

Transforming growth factor beta

TIA

Transient ischemic attack

TIME-CHF

Trial of Intensified vs standard Medical therapy in Elderly patients with Congestive Heart Failure

TN

True Negative

TOO

Task Order Officer

TP

True Positive

TPR

True-Positive Rates

Type D

type-D personality

UHFO-IA

Utrecht Heart Failure Organisation – Initial Assessment

UKNPS

United Kingdom Natriuretic Peptide Study

umol/L

Micromol per liter

UPSTEP

Use of PeptideS in Tailoring hEart failure Project

USA

United States of America

VAD

Ventricular Assist Device

VHD

Valvular heart disease

vs

versus

y

years

Cover of Use of Natriuretic Peptide Measurement in the Management of Heart Failure
Use of Natriuretic Peptide Measurement in the Management of Heart Failure [Internet].
Comparative Effectiveness Reviews, No. 126.
Balion C, Don-Wauchope A, Hill S, et al.

PubMed Health Blog...

read all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...